Literature DB >> 29626620

Genetic Contribution to Nonsquamous, Non-Small Cell Lung Cancer in Nonsmokers.

Shamus R Carr1, Wallace Akerley2, Lisa A Cannon-Albright3.   

Abstract

INTRODUCTION: Lung carcinogenesis is strongly influenced by environmental and heritable factors. The genetic contribution to the different histologic subtypes is unknown.
METHODS: A population-based computerized genealogy resource linked to a statewide cancer registry of lung cancer cases (N = 5408) was analyzed to evaluate the heritable contribution to lung cancer histologic subtype in smokers (n = 1751) and nonsmokers (n = 818). Statistical methods were used to test for significant excess relatedness of lung cancer cases.
RESULTS: Significant excess distant relatedness was observed for all lung cancer histologic subgroups analyzed except for the SCLC subset (p = 0.213). When histologic subsets of smokers and nonsmokers with lung cancer were considered, excess relatedness was observed only in nonsmokers with NSCLC (n = 653 [p = 0.026]) and, in particular, in those nonsmokers with the nonsquamous histologic subtype (n = 561 [p = 0.036]). A total of 61 pedigrees demonstrating a significant excess risk of nonsquamous lung cancer in nonsmokers were identified, and an excess of cases in females was observed among the individuals with these high-risk pedigrees.
CONCLUSIONS: This analysis supports a genetic predisposition to lung cancer carcinogenesis in nonsmokers with nonsquamous NSCLC.
Copyright © 2018 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma; Genetic predisposition; Histologic subtype; Lung cancer; Squamous cell carcinoma; UPDB

Mesh:

Year:  2018        PMID: 29626620     DOI: 10.1016/j.jtho.2018.03.024

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  6 in total

1.  The impact of patients' preferences on the decision of low-dose computed tomography lung cancer screening.

Authors:  Fu-Zong Wu; Pei-Lun Kuo; Carol C Wu; Ming-Ting Wu
Journal:  Transl Lung Cancer Res       Date:  2018-09

2.  Population-Based Relative Risks for Lung Cancer Based on Complete Family History of Lung Cancer.

Authors:  Lisa A Cannon-Albright; Shamus R Carr; Wallace Akerley
Journal:  J Thorac Oncol       Date:  2019-05-07       Impact factor: 15.609

3.  Lung Cancer in Li-Fraumeni Syndrome.

Authors:  Kathleen Kerrigan; Jessica Chan; Jennie Vagher; Wendy Kohlmann; Anne Naumer; Jo Anson; Sara Low; Joshua Schiffman; Luke Maese
Journal:  JCO Precis Oncol       Date:  2021-03-23

4.  Long non‑coding RNA HCG11 suppresses the malignant phenotype of non‑small cell lung cancer cells by targeting a miR‑875/SATB2 axis.

Authors:  Zhou Su; Mi Chen; Ruilin Ding; Lian Shui; Qingmei Zhao; Wenjuan Luo
Journal:  Mol Med Rep       Date:  2021-06-03       Impact factor: 2.952

5.  Gene polymorphism of cytochrome P450 significantly affects lung cancer susceptibility.

Authors:  Meng Li; Anqi Li; Ruiqing He; Wenhui Dang; Xinyu Liu; Tian Yang; Puyu Shi; Xiang Bu; Dan Gao; Ning Zhang; Shuli Du; Tianbo Jin; Mingwei Chen
Journal:  Cancer Med       Date:  2019-07-01       Impact factor: 4.452

6.  Circ-PITX1 Promotes the Progression of Non-Small Cell Lung Cancer Through Regulating the miR-1248/CCND2 Axis.

Authors:  Qianyu Yue; Yanyan Xu; Xiaoli Deng; Shenglan Wang; Jingman Qiu; Baojiang Qian; Yunhui Zhang
Journal:  Onco Targets Ther       Date:  2021-03-09       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.